PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION (PILMA
$0
$0
Filing Details
Type: ld2 • Year: 2026 Q1
IDs
Filing UUID:1ae18c8c-c4fa-4120-a0f8-d0e47ce27399
Registrant ID:36105
Client ID:53148
2026-03-23
TIBER CREEK GROUP
WE WORK FOR HEALTH
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to pharmaceutical innovation and pricing.
IDs
Filing UUID:33aa9062-a2b6-4ea3-bad3-80b203e6fa39
Registrant ID:20744
Client ID:212316
2026-03-23
ARNOLD & PORTER KAYE SCHOLER LLP
ESTEVE PHARMACEUTICALS, S.A.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to reimbursement and coverage for certain drugs.; Issues related to reimbursement and coverage for certain drugs.
IDs
Filing UUID:f644d85c-f8c0-4f13-878c-2fbf756e33db
Registrant ID:4301
Client ID:71935
2026-03-23
ARNOLD & PORTER KAYE SCHOLER LLP
SUMITOMO PHARMA AMERICA, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to prescription drug pricing, and issues related to small to mid-size pharmaceutical companies.; Issues related to prescription drug pricing, and issues related to small to mid-size pharmaceutical companies.
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA)
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to pharmaceutical compounding.
IDs
Filing UUID:861a079c-04eb-4a22-9454-d471767d139a
Registrant ID:320918
Client ID:71856
2026-03-10
ALB SOLUTIONS
VERTEX PHARMACEUTICALS
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Non-opioid pain relief and drug pipeline issues.
Registered Lobbyists (2)
ADAM BUCKALEW ●NEW— Covered Official Positions Continued: Deputy Chief of Staff, U.S. Rep. Markwayne Mullin (R-OK); Communications Director & Legislative Assistant, U.S. Rep. Gregg Harper (R-MS)VERONICA JACKSON ●NEW— Director, Strategic Planning, Office of the Assistant Secretary for Public Affairs, HHS
IDs
Filing UUID:48cd718d-a4e9-41fa-91e7-e86d91b5e7b1
Registrant ID:401105973
Client ID:71687
2026-03-09
MARSHALL & POPP, LLC
GLAXOSMITHKLINE
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to pharmaceutical manufacturing, drug pricing, trade and tariffs.; Issues related to pharmaceutical manufacturing, drug pricing, trade and tariffs.
Registered Lobbyists (2)
HAZEN MARSHALL ●NEW— Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don NicklesMONICA POPP ●NEW— Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint
IDs
Filing UUID:fb7fed96-f152-4700-bb3d-6cd848a19cac
Registrant ID:401105121
Client ID:71670
2026-03-02
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
KYOWA KIRIN, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to pharmaceuticals.; Issues related to pharmaceuticals.; Issues related to pharmaceuticals.; Issues related to pharmaceuticals.; Issues related to pharmaceuticals.; Issues related to pharmaceuticals.
Registered Lobbyists (2)
MICHAEL CORCORAN ●NEWROBERT BLAIR ●NEW
IDs
Filing UUID:c9cb5ae1-5448-40b7-8cc2-00927a5b951a
Registrant ID:401109009
Client ID:71534
2026-02-27
BALLARD PARTNERS
JUBILANT PHARMA HOLDINGS INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Trade/USMCA renegotiations; Domestic investment
Registered Lobbyists (2)
BRIAN BALLARD ●NEWHUNTER MORGEN ●NEW— Policy Advisor, Office of Policy Planning, U.S. State Dept. (2017); Deputy Director, Office of Trade & Manufacturing Policy, WH (2017-2018); Special Assistant to the President, Office of the Senior Advisor for Policy, WH (2018-2020)
IDs
Filing UUID:5b324631-b9e7-4b4e-bebe-cc2e66d649fb
Registrant ID:401104288
Client ID:71497
2026-02-27
THE CONAFAY GROUP, LLC
BRIGHT PATH LABORATORIES, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Policies that promote domestic pharmaceutical manufacturing.
Registered Lobbyists (2)
BRYAN SHUY ●NEW— Chief of Staff Rep. Harris; Asst. to Rep. Harris, House Cmte on Approps; Dep. Asst. Sec and Chief of Staff HHS/Asst.Secretary for Preparedness and Response (ASPR)JOSH NARROW ●NEW— Intern to Senator Casey
IDs
Filing UUID:dcefddf8-60b1-4e6c-973c-bd5ae32aff3f
Registrant ID:401004840
Client ID:71503
2026-02-24
FARRAGUT PARTNERS LLP
PIERRE FABRE PHARMACEUTICALS, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to FDA coverage of Tabelecucel
Registered Lobbyists (7)
CONSTANTINE HINGSON ●NEW— Chief of Staff, Senator Dan Coats; Counsel/Legislative Director, Senator Judd Gregg; General Counsel, Senator Elizabeth DoleDYLAN MOORE ●NEW— Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8); Intern, Rep. Mike Turner (OH-10)JEFF MACKINNON ●NEW— LD & LA Rep. Joe Barton (RTexas)JEFFERY MORTIER ●NEW— Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin NunesJODY GALE ●NEWSARAH WALTER ●NEW— Former Legislative Director/Chief Counsel, Sen. John BreauxWILLIAM KRIEGER ●NEW
IDs
Filing UUID:f38ac109-e174-49fc-bd38-3869ddf65ba7
Registrant ID:401103938
Client ID:71407
2026-02-24
MARSHALL & POPP, LLC
CURIE BIO OPERATIONS, LLC
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to the development, testing, and approval of pharmaceutical products.
Registered Lobbyists (2)
HAZEN MARSHALL ●NEW— Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don NicklesMONICA POPP ●NEW— Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint
IDs
Filing UUID:3b1ea2ee-1212-4dd5-8e46-63e0e7796400
Registrant ID:401105121
Client ID:71415
2026-02-24
MARSHALL & POPP, LLC
SUN PHARMACEUTICAL INDUSTRIES, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to pharmaceutical manufacturing. Drug pricing. Trade and tariffs.; Issues related to pharmaceutical manufacturing. Drug pricing. Trade and tariffs.
Registered Lobbyists (2)
HAZEN MARSHALL ●NEW— Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don NicklesMONICA POPP ●NEW— Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint
IDs
Filing UUID:d3713df3-ea05-437d-aa10-35c055f7a8d9
Registrant ID:401105121
Client ID:71417
2026-02-24
MARSHALL & POPP, LLC
BRISTOL-MYERS SQUIBB COMPANY
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to pharmaceutical manufacuring. Drug pricing. Trade and tariffs.; Issues related to pharmaceutical manufacuring. Drug pricing. Trade and tariffs.
Registered Lobbyists (2)
HAZEN MARSHALL ●NEW— Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don NicklesMONICA POPP ●NEW— Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint
IDs
Filing UUID:73dff0d9-7042-4636-8fea-54f90781ad75
Registrant ID:401105121
Client ID:71418
2026-02-24
MARSHALL & POPP, LLC
DAIICHI SANKYO, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to pharmaceutical manufacturing and drug pricing. Issues related to trade and tariffs.; Issues related to pharmaceutical manufacturing and drug pricing. Issues related to trade and tariffs.
Registered Lobbyists (2)
HAZEN MARSHALL ●NEW— Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don NicklesMONICA POPP ●NEW— Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint
IDs
Filing UUID:0dde4e28-b044-496a-89f0-bb48708af48c
Registrant ID:401105121
Client ID:71431
2026-02-19
CONTINENTAL STRATEGY, LLC
IMMIX BIOPHARMA, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to the FDA
Registered Lobbyists (2)
LUKE NICKLESS ●NEW— Senior Policy Advisor, Appropriations, House Committee on the BudgetTIMOTHY COSTA ●NEW— Chief of Staff to Dan Meuser
IDs
Filing UUID:03c76883-a9f0-4ac8-a7dc-d60387645b34
Registrant ID:401106285
Client ID:71337
2026-02-19
K&L GATES, LLP
BORYUNG CORPORATION
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Pharmaceutical and life sciences research in space.; Pharmaceutical and life sciences research in space.; Pharmaceutical and life sciences research in space.
Registered Lobbyists (2)
MICHAEL HEARD SNOW ●NEW— Extern, House Select Cmte on Climate CrisisVARUN JAIN ●NEW— Dep GC, USDOT; Sr. Counselor to OIRA Admin, OMB; Asst GC, OMB; Econ & Legal Fellow, Sen. Whitehouse
IDs
Filing UUID:35b5c741-ffe0-43cd-966f-d9399f24a670
Registrant ID:32098
Client ID:71342
2026-02-18
W STRATEGIES, LLC
BRISTOL-MYERS SQUIBB COMPANY
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Education about the value of biopharmaceutical innovation and related issues.
Registered Lobbyists (1)
DARREN WILLCOX ●NEW— Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director
IDs
Filing UUID:4665d562-d7d6-4324-8a6a-6c0e6a8c7581
Registrant ID:400605842
Client ID:71322
2026-02-18
CAPITOL COUNSEL LLC
MADRIGAL PHARMACEUTICALS, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
FDA and regulatory issues related to the biopharmaceutical industry.; FDA and regulatory issues related to the biopharmaceutical industry.; FDA and regulatory issues related to the biopharmaceutical industry.
Registered Lobbyists (7)
ANN JABLON ●NEW— Chief of Staff, Rep. Richard E. Neal; Legislative Director, Rep. Richard E. Neal; Administrative Assistant, Rep. Richard E. Neal; Executive/ Legislative Assistant, Rep. Richard E. Neal.CHARLES MICHAELS ●NEW— Chief of Staff, Deputy Chief of Staff, Legislative Director, Senior Legislative Assistant, and Legislative Assistant, Rep. David Schweikert; Staff Assistant, Rep. Ted Budd; Intern, Senator James DeMint.GEORGE SIFAKIS ●NEW— Assistant to the President of the United States and Director of the Office of Public Liaison (President Trump, 2017).JEFFREY CARROLL ●NEW— Staff Director House Energy and Commerce Committee; Chief of Staff, Rep. Frank Pallone.JOHN MARTIN ●NEW— Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton.LYNDON BOOZER ●NEWSHANNON FINLEY ●NEW
IDs
Filing UUID:66453105-53de-4d9f-b8b3-a837e3cc00eb
Registrant ID:313715
Client ID:71323
2026-02-13
CROSSROADS STRATEGIES, LLC
ALKERMES, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Policiesimpacting pharmaceutical development, patient access, drug pricing, and supply chain.
Registered Lobbyists (4)
CHERYL JAEGER ●NEW— Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep. Cantor; Sr Policy Adv, Republican Whip, Rep. Cantor; Sr Policy Adv, Majority Whip, Rep. Blunt; Prof Staff House Committee on E & C; Sr LA to Rep. CoxJASON VAN PELT ●NEW— Legislative Director, Senior Legislative Asst, Legislative Asst, Staff Asst: Rep. Ed WhitfieldMATHEW LAPINSKI ●NEWSTEPHEN VOLJAVEC ●NEW— Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn
IDs
Filing UUID:bfb856dc-4047-4b07-83f6-65c561fe6983
Registrant ID:400531586
Client ID:192194
2026-02-13
MONUMENT ADVOCACY
CENCORA
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician FeeSchedule Proposed Rule.
Registered Lobbyists (2)
COLTON HENNING ●NEWJOEL WHITE ●NEW— Staff Director, Ways & Means Health Subcommittee; L.A. for Rep. Jim Greenwood; L.A. for Rep. Chris Shays
IDs
Filing UUID:6de75cc0-14cc-4d64-8db0-d32ddde1f3b0
Registrant ID:308775
Client ID:71234
2026-02-11
SONORAN POLICY GROUP, LLC D/B/A STRYK GLOBAL DIPLOMACY, FORMERLY KNOWN AS SONORA
COLLEGIUM PHARMACEUTICAL, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
U.S. Executive Branch engagement
Registered Lobbyists (4)
CHRISTIAN BOURGE ●NEWNICHOLAS VANDER POEL ●NEWROBERT STRYK ●NEWTIMOTHY CURRY ●NEW
IDs
Filing UUID:3255e75a-038b-4cc2-9d8f-1ad9142bd188
Registrant ID:298158
Client ID:71155
2026-02-11
VENABLE LLP
STRIVE SPECIALTIES, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to pharmaceutical industry oversight
Registered Lobbyists (5)
DEAN HELLER ●NEW— US Senator; US House RepresentativeDEEPTI LOHARIKAR ●NEWJOHN V. DRZEWICKI ●NEW— Staff Assistant, Rep. Steve Austria; Policy Advisor, US House of Representatives; Policy Director, House Republican ConferenceJOSH FINESTONE ●NEW— Legislative Assistant, Rep. Mike Rogers; Legislative Director, Rep. Tom Graves; Legislative Assistant, Sen. Dean Heller; Senior Legislative Assistant, Sen. Dean Heller; Professional Staff, Senate Committee on Commerce, Science and TransportationLAURA HANEN ●NEW